Other Species / Isoforms
  GJA1 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MGDWsALGKLLD
0 3
GJA1 (human) ___MGDWSALGkLLD S5
GJA1 (mouse) ___MGDWsALGkLLD S5-p
GJA1 (rat) ___MGDWsALGKLLD S5-p
GJA1 (rabbit) ___MGDWSALGKLLD S5
GJA1 (pig) ___MGDWSALGKLLD S5
GJA1 (hamster) ___MGDWSALGKLLD S5
GJA1 (cow) ___MGDWSALGKLLD S5
K9
GDWsALGKLLDKVQA
0 2
GJA1 (human) GDWSALGkLLDKVQA K9-ub
GJA1 (mouse) GDWsALGkLLDKVQA K9-ub
GJA1 (rat) GDWsALGKLLDKVQA K9
GJA1 (rabbit) GDWSALGKLLDKVQA K9
GJA1 (pig) GDWSALGKLLDKVQA K9
GJA1 (hamster) GDWSALGKLLDKVQA K9
GJA1 (cow) GDWSALGKLLDKVQA K9
K108
RKEEKLNKkEEELKV
0 1
GJA1 (human) RKEEKLNKkEEELKV K108
GJA1 (mouse) RKEEKLNkkEEELKV K108-ub
GJA1 (rat) RKEEKLNKkEEELKV K108
GJA1 (rabbit) RKEEKLNKKEEELKV K108
GJA1 (pig) RKEEKLNKKEEELKV K108
GJA1 (hamster) RKEEKLNKKEEELKV K108
GJA1 (cow) RKEEKLNKKEEELKV K108
K109-ub
KEEKLNKkEEELKVA
0 17
GJA1 (human) KEEKLNKkEEELKVA K109-ub
GJA1 (mouse) KEEKLNkkEEELKVA K109-ub
GJA1 (rat) KEEKLNKkEEELKVA K109-ub
GJA1 (rabbit) KEEKLNKKEEELKVA K109
GJA1 (pig) KEEKLNKKEEELKVA K109
GJA1 (hamster) KEEKLNKKEEELKVA K109
GJA1 (cow) KEEKLNKKEEELKVV K109
K128-ub
VNVEMHLkQIEIkkF
0 10
GJA1 (human) VNVDMHLkQIEIKKF K128-ub
GJA1 (mouse) VNVEMHLkQIEIkKF K128-ub
GJA1 (rat) VNVEMHLkQIEIkkF K128-ub
GJA1 (rabbit) VNVEMHLKQIEIKKF K128
GJA1 (pig) VNVEMHLKQIEIKKF K128
GJA1 (hamster) ANVDMHLKQIEIKKF K128
GJA1 (cow) ANVDMHLKQIEIKKF K129
K133
HLkQIEIKkFkyGIE
0 1
GJA1 (human) HLkQIEIKKFkyGIE K133
GJA1 (mouse) HLkQIEIkKFkyGIE K133-ub
GJA1 (rat) HLkQIEIKkFkyGIE K133
GJA1 (rabbit) HLKQIEIKKFKYGIE K133
GJA1 (pig) HLKQIEIKKFKYGIE K133
GJA1 (hamster) HLKQIEIKKFKYGIE K133
GJA1 (cow) HLKQIEIKKFKYGIE K134
K133-ac
HLkQIEIkkFkyGIE
0 1
GJA1 (human) HLkQIEIKKFkyGIE K133
GJA1 (mouse) HLkQIEIKKFkyGIE K133
GJA1 (rat) HLkQIEIkkFkyGIE K133-ac
GJA1 (rabbit) HLKQIEIKKFKYGIE K133
GJA1 (pig) HLKQIEIKKFKYGIE K133
GJA1 (hamster) HLKQIEIKKFKYGIE K133
GJA1 (cow) HLKQIEIKKFKYGIE K134
K134-ub
LkQIEIkkFkyGIEE
0 1
GJA1 (human) LkQIEIKKFkyGIEE K134
GJA1 (mouse) LkQIEIkKFkyGIEE K134
GJA1 (rat) LkQIEIkkFkyGIEE K134-ub
GJA1 (rabbit) LKQIEIKKFKYGIEE K134
GJA1 (pig) LKQIEIKKFKYGIEE K134
GJA1 (hamster) LKQIEIKKFKYGIEE K134
GJA1 (cow) LKQIEIKKFKYGIEE K135
K136-ub
QIEIkkFkyGIEEHG
0 5
GJA1 (human) QIEIKKFkyGIEEHG K136-ub
GJA1 (mouse) QIEIkKFkyGIEEHG K136-ub
GJA1 (rat) QIEIkkFkyGIEEHG K136-ub
GJA1 (rabbit) QIEIKKFKYGIEEHG K136
GJA1 (pig) QIEIKKFKYGIEEHG K136
GJA1 (hamster) QIEIKKFKYGIEEHG K136
GJA1 (cow) QIEIKKFKYGIEEHG K137
Y137-p
IEIkkFkyGIEEHGK
0 22
GJA1 (human) IEIKKFkyGIEEHGk Y137-p
GJA1 (mouse) IEIkKFkyGIEEHGk Y137-p
GJA1 (rat) IEIkkFkyGIEEHGK Y137-p
GJA1 (rabbit) IEIKKFKYGIEEHGK Y137
GJA1 (pig) IEIKKFKYGIEEHGK Y137
GJA1 (hamster) IEIKKFKYGIEEHGK Y137
GJA1 (cow) IEIKKFKYGIEEHGK Y138
K144
yGIEEHGKVKMRGGL
0 2
GJA1 (human) yGIEEHGkVKMRGGL K144-ub
GJA1 (mouse) yGIEEHGkVKMRGGL K144-ub
GJA1 (rat) yGIEEHGKVKMRGGL K144
GJA1 (rabbit) YGIEEHGKVKMRGGL K144
GJA1 (pig) YGIEEHGKVKMRGGL K144
GJA1 (hamster) YGIEEHGKVKMRGGL K144
GJA1 (cow) YGIEEHGKVKMRGGL K145
R243
VKDRVKGRsDPyHAT
0 4
GJA1 (human) VKDRVKGksDPyHAt K243-ub
GJA1 (mouse) VKDRVKGRSDPyHAt R243
GJA1 (rat) VKDRVKGRsDPyHAT R243
GJA1 (rabbit) VKDRVKGKSDPYHAT K243
GJA1 (pig) VKDRVKGKSDPYHAT K243
GJA1 (hamster) VKDRVKGRSDPYHAT R243
GJA1 (cow) VKDRVKGKSDPYHTT K244
S244-p
KDRVKGRsDPyHATT
Upstream
0 8
Kinase, in vitro:
  • CAMK2A (human)
GJA1 (human) KDRVKGksDPyHAts S244-p
GJA1 (mouse) KDRVKGRSDPyHAtT S244
GJA1 (rat) KDRVKGRsDPyHATT S244-p
GJA1 (rabbit) KDRVKGKSDPYHATT S244
GJA1 (pig) KDRVKGKSDPYHATT S244
GJA1 (hamster) KDRVKGRSDPYHATT S244
GJA1 (cow) KDRVKGKSDPYHTTT S245
Y247-p
VKGRsDPyHATTGPL
Upstream
Downstream
14 256
Effects on Modified Protein
  • activity, induced
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, altered
  • cell growth, altered
  • cytoskeletal reorganization
Kinase, in vitro:
  • Pyk2 (rat)
  • Src (human)
  • Tyk2 (human)
Phosphatases, in vitro:
  • PTPN2 (human)
Putative in vivo kinases:
  • Pyk2 (rat)
  • Src (human)
  • Tyk2 (human)
Putative upstream phosphatases:
  • PTPN2 (human)
Regulatory protein:
  • Src (rat)
Treatment
  • angiotensin_2
  • EGF
  • PF4618433
  • phorbol_ester
  • saracatinib
  • siRNA
GJA1 (human) VKGksDPyHAtsGAL Y247-p
GJA1 (mouse) VKGRSDPyHAtTGPL Y247-p
GJA1 (rat) VKGRsDPyHATTGPL Y247-p
GJA1 (rabbit) VKGKSDPYHATTGPL Y247
GJA1 (pig) VKGKSDPYHATTGPL Y247
GJA1 (hamster) VKGRSDPYHATTGPL Y247
GJA1 (cow) VKGKSDPYHTTTGPL Y248
T250
RsDPyHATTGPLsPs
0 6
GJA1 (human) ksDPyHAtsGALsPA T250-p
GJA1 (mouse) RSDPyHAtTGPLsPs T250-p
GJA1 (rat) RsDPyHATTGPLsPs T250
GJA1 (rabbit) KSDPYHATTGPLSPS T250
GJA1 (pig) KSDPYHATTGPLsPS T250
GJA1 (hamster) RSDPYHATTGPLNPS T250
GJA1 (cow) KSDPYHTTTGPLSPS T251
T251
sDPyHATTGPLsPsk
0 5
GJA1 (human) sDPyHAtsGALsPAk S251-p
GJA1 (mouse) SDPyHAtTGPLsPsk T251
GJA1 (rat) sDPyHATTGPLsPsk T251
GJA1 (rabbit) SDPYHATTGPLSPSK T251
GJA1 (pig) SDPYHATTGPLsPSK T251
GJA1 (hamster) SDPYHATTGPLNPSK T251
GJA1 (cow) SDPYHTTTGPLSPSK T252
S255-p
HATTGPLsPskDCGs
Upstream
Downstream
21 21
Effects on Modified Protein
  • activity, inhibited
Kinase, in vitro:
  • CAMK2A (human)
  • ERK1 (rat)
  • ERK2 (mouse)
  • ERK5 (human)
Putative in vivo kinases:
  • ERK5 (human)
Treatment
  • albumin
  • EGF
  • LPA
  • PD98059
  • vanadate
GJA1 (human) HAtsGALsPAkDCGs S255-p
GJA1 (mouse) HAtTGPLsPskDCGs S255-p
GJA1 (rat) HATTGPLsPskDCGs S255-p
GJA1 (rabbit) HATTGPLSPSKDCGS S255
GJA1 (pig) HATTGPLsPSKDCGs S255-p
GJA1 (hamster) HATTGPLNPSKDCGS N255
GJA1 (cow) HTTTGPLSPSKDCGS S256
S257-p
TTGPLsPskDCGsPk
Upstream
Downstream
1 8
Effects on Modified Protein
  • activity, inhibited
Kinase, in vitro:
  • CAMK2A (human)
Treatment
  • 2,2'-DCB
  • PD184352
  • PD98059
  • serum
GJA1 (human) tsGALsPAkDCGsQk A257
GJA1 (mouse) tTGPLsPskDCGsPk S257-p
GJA1 (rat) TTGPLsPskDCGsPk S257-p
GJA1 (rabbit) TTGPLSPSKDCGSPK S257
GJA1 (pig) TTGPLsPSKDCGsPK S257
GJA1 (hamster) TTGPLNPSKDCGSPK S257
GJA1 (cow) TTGPLSPSKDCGSPK S258
K258-ub
TGPLsPskDCGsPky
0 38
GJA1 (human) sGALsPAkDCGsQky K258-ub
GJA1 (mouse) TGPLsPskDCGsPky K258-ub
GJA1 (rat) TGPLsPskDCGsPky K258-ub
GJA1 (rabbit) TGPLSPSKDCGSPKY K258
GJA1 (pig) TGPLsPSKDCGsPKY K258
GJA1 (hamster) TGPLNPSKDCGSPKY K258
GJA1 (cow) TGPLSPSKDCGSPKY K259
S262-p
sPskDCGsPkyAyFN
Upstream
Downstream
29 9
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, altered
  • cell growth, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • PKCA (rat)
  • PKCE (rat)
Regulatory protein:
  • GJA1 (human)
  • IP3R1 (rat)
  • TGFBR2 (rat)
Treatment
  • 2-APB
  • albumin
  • epsilonV1-2
  • FGF2
  • ischemia
  • phorbol_ester
  • SB431542
  • TGF-beta
GJA1 (human) sPAkDCGsQkyAyFN S262-p
GJA1 (mouse) sPskDCGsPkyAyFN S262-p
GJA1 (rat) sPskDCGsPkyAyFN S262-p
GJA1 (rabbit) SPSKDCGSPKYAYFN S262
GJA1 (pig) sPSKDCGsPKYAYFN S262-p
GJA1 (hamster) NPSKDCGSPKYAYFN S262
GJA1 (cow) SPSKDCGSPKYAYFN S263
K264-ub
skDCGsPkyAyFNGC
1 16
GJA1 (human) AkDCGsQkyAyFNGC K264-ub
GJA1 (mouse) skDCGsPkyAyFNGC K264-ub
GJA1 (rat) skDCGsPkyAyFNGC K264-ub
GJA1 (rabbit) SKDCGSPKYAYFNGC K264
GJA1 (pig) SKDCGsPKYAYFNGC K264
GJA1 (hamster) SKDCGSPKYAYFNGC K264
GJA1 (cow) SKDCGSPKYAYFNGC K265
Y265-p
kDCGsPkyAyFNGCS
Upstream
Downstream
25 15
Effects on Modified Protein
  • activity, induced
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, altered
  • cell adhesion, altered
  • cell growth, altered
  • cytoskeletal reorganization
Kinase, in vitro:
  • Pyk2 (rat)
  • Src (human)
  • Src (rat)
  • Tyk2 (human)
Phosphatases, in vitro:
  • PTPN2 (human)
Putative in vivo kinases:
  • Pyk2 (rat)
  • Src (human)
  • Src (rat)
  • Tyk2 (human)
Putative upstream phosphatases:
  • PTPN2 (human)
Regulatory protein:
  • Src (rat)
Treatment
  • albumin
  • angiotensin_2
  • EGF
  • ouabain
  • PF4618433
  • phorbol_ester
  • saracatinib
  • siRNA
GJA1 (human) kDCGsQkyAyFNGCs Y265-p
GJA1 (mouse) kDCGsPkyAyFNGCS Y265-p
GJA1 (rat) kDCGsPkyAyFNGCS Y265-p
GJA1 (rabbit) KDCGSPKYAYFNGCS Y265
GJA1 (pig) KDCGsPKYAYFNGCS Y265
GJA1 (hamster) KDCGSPKYAYFNGCS Y265
GJA1 (cow) KDCGSPKYAYFNGCS Y266
Y267-p
CGsPkyAyFNGCSSP
Upstream
1 12
Kinase, in vitro:
  • Pyk2 (rat)
  • Tyk2 (human)
GJA1 (human) CGsQkyAyFNGCsSP Y267-p
GJA1 (mouse) CGsPkyAyFNGCSsP Y267-p
GJA1 (rat) CGsPkyAyFNGCSSP Y267-p
GJA1 (rabbit) CGSPKYAYFNGCSSP Y267
GJA1 (pig) CGsPKYAYFNGCSSP Y267
GJA1 (hamster) CGSPKYAYFNGCSSP Y267
GJA1 (cow) CGSPKYAYFNGCSSP Y268
S272
yAyFNGCSSPTAPLs
0 1
GJA1 (human) yAyFNGCsSPtAPLs S272-p
GJA1 (mouse) yAyFNGCSsPtAPLs S272
GJA1 (rat) yAyFNGCSSPTAPLs S272
GJA1 (rabbit) YAYFNGCSSPTAPLS S272
GJA1 (pig) YAYFNGCSSPTAPLs S272
GJA1 (hamster) YAYFNGCSSPTAPLS S272
GJA1 (cow) YAYFNGCSSPTAPLS S273
S273
AyFNGCSSPTAPLsP
0 2
GJA1 (human) AyFNGCsSPtAPLsP S273
GJA1 (mouse) AyFNGCSsPtAPLsP S273-p
GJA1 (rat) AyFNGCSSPTAPLsP S273
GJA1 (rabbit) AYFNGCSSPTAPLSP S273
GJA1 (pig) AYFNGCSSPTAPLsP S273
GJA1 (hamster) AYFNGCSSPTAPLSP S273
GJA1 (cow) AYFNGCSSPTAPLSP S274
T275
FNGCSSPTAPLsPMs
0 2
GJA1 (human) FNGCsSPtAPLsPMs T275-p
GJA1 (mouse) FNGCSsPtAPLsPMs T275-p
GJA1 (rat) FNGCSSPTAPLsPMs T275
GJA1 (rabbit) FNGCSSPTAPLSPMS T275
GJA1 (pig) FNGCSSPTAPLsPMs T275
GJA1 (hamster) FNGCSSPTAPLSPMS T275
GJA1 (cow) FNGCSSPTAPLSPMS T276
S279-p
SSPTAPLsPMsPPGY
Upstream
Downstream
42 6
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • endocytosis, induced
Kinase, in vitro:
  • ERK1 (rat)
  • ERK2 (mouse)
Putative in vivo kinases:
  • ERK1 (rat)
  • ERK2 (rat)
Regulatory protein:
  • DSG4 (human)
  • IP3R1 (rat)
  • Tyk2 (human)
Treatment
  • 2-APB
  • adriamycin
  • albumin
  • angiotensin_2
  • ATP
  • BQ
  • DEM
  • DMNQ
  • EGF
  • IP3/BM
  • isoproterenol
  • LPA
  • menadione
  • miRNA
  • PD98059
  • phorbol_ester
  • U0126
  • valsartan
  • vanadate
GJA1 (human) sSPtAPLsPMsPPGy S279-p
GJA1 (mouse) SsPtAPLsPMsPPGy S279-p
GJA1 (rat) SSPTAPLsPMsPPGY S279-p
GJA1 (rabbit) SSPTAPLSPMSPPGY S279
GJA1 (pig) SSPTAPLsPMsPPGY S279-p
GJA1 (hamster) SSPTAPLSPMSPPGY S279
GJA1 (cow) SSPTAPLSPMSPPGY S280
S282-p
TAPLsPMsPPGYkLV
Upstream
Downstream
42 7
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, induced
  • apoptosis, inhibited
Kinase, in vitro:
  • ERK1 (rat)
  • ERK2 (mouse)
Putative in vivo kinases:
  • ERK1 (rat)
  • ERK2 (rat)
Regulatory protein:
  • IP3R1 (rat)
  • Tyk2 (human)
Treatment
  • 2-APB
  • adriamycin
  • albumin
  • angiotensin_2
  • ATP
  • BQ
  • CBX
  • DEM
  • DMNQ
  • EGF
  • IP3/BM
  • isoproterenol
  • LPA
  • menadione
  • miRNA
  • PD98059
  • phorbol_ester
  • U0126
  • valsartan
  • vanadate
GJA1 (human) tAPLsPMsPPGykLV S282-p
GJA1 (mouse) tAPLsPMsPPGykLV S282-p
GJA1 (rat) TAPLsPMsPPGYkLV S282-p
GJA1 (rabbit) TAPLSPMSPPGYKLV S282
GJA1 (pig) TAPLsPMsPPGYKLV S282-p
GJA1 (hamster) TAPLSPMSPPGYKLV S282
GJA1 (cow) TAPLSPMSPPGYKLV S283
Y286
sPMsPPGYkLVTGDR
1 12
GJA1 (human) sPMsPPGykLVtGDR Y286-p
GJA1 (mouse) sPMsPPGykLVtGDR Y286-p
GJA1 (rat) sPMsPPGYkLVTGDR Y286
GJA1 (rabbit) SPMSPPGYKLVTGDR Y286
GJA1 (pig) sPMsPPGYKLVTGDR Y286
GJA1 (hamster) SPMSPPGYKLVTGDR Y286
GJA1 (cow) SPMSPPGYKLVTGDR Y287
K287-ub
PMsPPGYkLVTGDRN
0 7
GJA1 (human) PMsPPGykLVtGDRN K287-ub
GJA1 (mouse) PMsPPGykLVtGDRN K287-ub
GJA1 (rat) PMsPPGYkLVTGDRN K287-ub
GJA1 (rabbit) PMSPPGYKLVTGDRN K287
GJA1 (pig) PMsPPGYKLVTGDRN K287
GJA1 (hamster) PMSPPGYKLVTGDRN K287
GJA1 (cow) PMSPPGYKLVTGDRN K288
T290
PPGYkLVTGDRNNss
0 5
GJA1 (human) PPGykLVtGDRNNss T290-p
GJA1 (mouse) PPGykLVtGDRNNss T290-p
GJA1 (rat) PPGYkLVTGDRNNss T290
GJA1 (rabbit) PPGYKLVTGDRNNSS T290
GJA1 (pig) PPGYKLVTGDRNNSS T290
GJA1 (hamster) PPGYKLVTGDRNNSS T290
GJA1 (cow) PPGYKLVTGDRNNSs T291
S296-p
VTGDRNNssCRNYNk
Upstream
1 14
Kinase, in vitro:
  • CAMK2A (human)
GJA1 (human) VtGDRNNssCRNyNk S296-p
GJA1 (mouse) VtGDRNNssCRNyNk S296-p
GJA1 (rat) VTGDRNNssCRNYNk S296-p
GJA1 (rabbit) VTGDRNNSSCRNYNK S296
GJA1 (pig) VTGDRNNSSCRNYNK S296
GJA1 (hamster) VTGDRNNSSCRNYNK S296
GJA1 (cow) VTGDRNNSsCRNYNK S297
S297-p
TGDRNNssCRNYNkQ
Upstream
2 12
Kinase, in vitro:
  • CAMK2A (human)
Treatment
  • ischemia
  • rotigaptide
GJA1 (human) tGDRNNssCRNyNkQ S297-p
GJA1 (mouse) tGDRNNssCRNyNkQ S297-p
GJA1 (rat) TGDRNNssCRNYNkQ S297-p
GJA1 (rabbit) TGDRNNSSCRNYNKQ S297
GJA1 (pig) TGDRNNSSCRNYNKQ S297
GJA1 (hamster) TGDRNNSSCRNYNKQ S297
GJA1 (cow) TGDRNNSsCRNYNKQ S298-p
Y301
NNssCRNYNkQAsEQ
0 8
GJA1 (human) NNssCRNyNkQAsEQ Y301-p
GJA1 (mouse) NNssCRNyNkQAsEQ Y301-p
GJA1 (rat) NNssCRNYNkQAsEQ Y301
GJA1 (rabbit) NNSSCRNYNKQASEQ Y301
GJA1 (pig) NNSSCRNYNKQASEQ Y301
GJA1 (hamster) NNSSCRNYNKQASEQ Y301
GJA1 (cow) NNSsCRNYNKQASEQ Y302
K303-ub
ssCRNYNkQAsEQNW
1 30
GJA1 (human) ssCRNyNkQAsEQNW K303-ub
GJA1 (mouse) ssCRNyNkQAsEQNW K303-ub
GJA1 (rat) ssCRNYNkQAsEQNW K303-ub
GJA1 (rabbit) SSCRNYNKQASEQNW K303
GJA1 (pig) SSCRNYNKQASEQNW K303
GJA1 (hamster) SSCRNYNKQASEQNW K303
GJA1 (cow) SsCRNYNKQASEQNW K304
S306-p
RNYNkQAsEQNWANy
Upstream
Downstream
1 22
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • CAMK2A (human)
Treatment
  • ischemia
GJA1 (human) RNyNkQAsEQNWANy S306-p
GJA1 (mouse) RNyNkQAsEQNWANy S306-p
GJA1 (rat) RNYNkQAsEQNWANy S306-p
GJA1 (rabbit) RNYNKQASEQNWANY S306
GJA1 (pig) RNYNKQASEQNWANY S306
GJA1 (hamster) RNYNKQASEQNWANY S306
GJA1 (cow) RNYNKQASEQNWANY S307
Y313-p
sEQNWANysAEQNRM
Upstream
Downstream
4 317
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • Pyk2 (rat)
  • Tyk2 (human)
Putative in vivo kinases:
  • Pyk2 (rat)
Regulatory protein:
  • Src (rat)
Treatment
  • EGF
  • PF4618433
  • phorbol_ester
  • saracatinib
  • siRNA
GJA1 (human) sEQNWANysAEQNRM Y313-p
GJA1 (mouse) sEQNWANysAEQNRM Y313-p
GJA1 (rat) sEQNWANysAEQNRM Y313-p
GJA1 (rabbit) SEQNWANYSAEQNRM Y313
GJA1 (pig) SEQNWANYSAEQNRM Y313
GJA1 (hamster) SEQNWANYSAEQNRM Y313
GJA1 (cow) SEQNWANYSAEQNRM Y314
S314-p
EQNWANysAEQNRMG
Upstream
0 12
Kinase, in vitro:
  • CAMK2A (human)
GJA1 (human) EQNWANysAEQNRMG S314-p
GJA1 (mouse) EQNWANysAEQNRMG S314-p
GJA1 (rat) EQNWANysAEQNRMG S314-p
GJA1 (rabbit) EQNWANYSAEQNRMG S314
GJA1 (pig) EQNWANYSAEQNRMG S314
GJA1 (hamster) EQNWANYSAEQNRMG S314
GJA1 (cow) EQNWANYSAEQNRMG S315
S325-p
NRMGQAGstIsNsHA
Upstream
Downstream
9 13
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell adhesion, altered
  • cell adhesion, induced
  • signaling pathway regulation
Kinase, in vitro:
  • CAMK2A (human)
  • CK1A (human)
Putative in vivo kinases:
  • CK1A (human)
Regulatory protein:
  • FGFR1 (rat)
Treatment
  • PD184352
  • serum
GJA1 (human) NRMGQAGstIsNsHA S325-p
GJA1 (mouse) NRMGQAGstIsNsHA S325-p
GJA1 (rat) NRMGQAGstIsNsHA S325-p
GJA1 (rabbit) NRMGQAGSTISNSHA S325
GJA1 (pig) NRMGQAGSTISNSHA S325
GJA1 (hamster) NRMGQAGSTISNSHA S325
GJA1 (cow) NRMGQAGSTISNSHA S326
T326-p
RMGQAGstIsNsHAQ
Upstream
0 11
Treatment
  • PD184352
  • serum
GJA1 (human) RMGQAGstIsNsHAQ T326-p
GJA1 (mouse) RMGQAGstIsNsHAQ T326-p
GJA1 (rat) RMGQAGstIsNsHAQ T326-p
GJA1 (rabbit) RMGQAGSTISNSHAQ T326
GJA1 (pig) RMGQAGSTISNSHAQ T326
GJA1 (hamster) RMGQAGSTISNSHAQ T326
GJA1 (cow) RMGQAGSTISNSHAQ T327
S328-p
GQAGstIsNsHAQPF
Upstream
Downstream
10 12
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell adhesion, altered
  • cell adhesion, induced
  • signaling pathway regulation
Kinase, in vitro:
  • CAMK2A (human)
  • CK1A (human)
Putative in vivo kinases:
  • CK1A (human)
Regulatory protein:
  • FGFR1 (rat)
Treatment
  • serum
GJA1 (human) GQAGstIsNsHAQPF S328-p
GJA1 (mouse) GQAGstIsNsHAQPF S328-p
GJA1 (rat) GQAGstIsNsHAQPF S328-p
GJA1 (rabbit) GQAGSTISNSHAQPF S328
GJA1 (pig) GQAGSTISNSHAQPF S328
GJA1 (hamster) GQAGSTISNSHAQPF S328
GJA1 (cow) GQAGSTISNSHAQPF S329
S330-p
AGstIsNsHAQPFDF
Upstream
Downstream
9 13
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell adhesion, altered
  • cell adhesion, induced
  • signaling pathway regulation
Kinase, in vitro:
  • CAMK2A (human)
  • CK1A (human)
Putative in vivo kinases:
  • CK1A (human)
Regulatory protein:
  • FGFR1 (rat)
Treatment
  • ischemia
  • PD184352
  • serum
GJA1 (human) AGstIsNsHAQPFDF S330-p
GJA1 (mouse) AGstIsNsHAQPFDF S330-p
GJA1 (rat) AGstIsNsHAQPFDF S330-p
GJA1 (rabbit) AGSTISNSHAQPFDF S330
GJA1 (pig) AGSTISNSHAQPFDF S330
GJA1 (hamster) AGSTISNSHAQPFDF S330
GJA1 (cow) AGSTISNSHAQPFDF S331
N341
PFDFPDDNQNAKKVA
0 2
GJA1 (human) PFDFPDDNQNskkLA N341
GJA1 (mouse) PFDFPDDsQNAkkVA S341-p
GJA1 (rat) PFDFPDDNQNAKKVA N341
GJA1 (rabbit) PFDFPDDNQNSKKLA N341
GJA1 (pig) PFDFPDDNQNSKKLD N341
GJA1 (hamster) PFDFPDDNQNAKKIA N341
GJA1 (cow) PFDFPDDHQNSKKLD H342
A344
FPDDNQNAKKVAAGH
0 2
GJA1 (human) FPDDNQNskkLAAGH S344-p
GJA1 (mouse) FPDDsQNAkkVAAGH A344
GJA1 (rat) FPDDNQNAKKVAAGH A344
GJA1 (rabbit) FPDDNQNSKKLAAGH S344
GJA1 (pig) FPDDNQNSKKLDAGH S344
GJA1 (hamster) FPDDNQNAKKIAAGH A344
GJA1 (cow) FPDDHQNSKKLDAGH S345
K345
PDDNQNAKKVAAGHE
0 12
GJA1 (human) PDDNQNskkLAAGHE K345-ub
GJA1 (mouse) PDDsQNAkkVAAGHE K345-ub
GJA1 (rat) PDDNQNAKKVAAGHE K345
GJA1 (rabbit) PDDNQNSKKLAAGHE K345
GJA1 (pig) PDDNQNSKKLDAGHE K345
GJA1 (hamster) PDDNQNAKKIAAGHE K345
GJA1 (cow) PDDHQNSKKLDAGHE K346
K346
DDNQNAKKVAAGHEL
0 7
GJA1 (human) DDNQNskkLAAGHEL K346-ub
GJA1 (mouse) DDsQNAkkVAAGHEL K346-ub
GJA1 (rat) DDNQNAKKVAAGHEL K346
GJA1 (rabbit) DDNQNSKKLAAGHEL K346
GJA1 (pig) DDNQNSKKLDAGHEL K346
GJA1 (hamster) DDNQNAKKIAAGHEL K346
GJA1 (cow) DDHQNSKKLDAGHEL K347
S364-p
AIVDQRPssRAssRA
Upstream
5 7
Kinase, in vitro:
  • CAMK2A (human)
  • PKCA (human)
  • PKCE (human)
Treatment
  • cAMP_analog
  • hypoxia
GJA1 (human) AIVDQRPssRAssRA S364-p
GJA1 (mouse) AIVDQRPssRAssRA S364-p
GJA1 (rat) AIVDQRPssRAssRA S364-p
GJA1 (rabbit) AIVDQRPSSRASsRA S364
GJA1 (pig) AIVDQRPSSRAsSRA S364
GJA1 (hamster) AIVDQRPSSRASSRA S364
GJA1 (cow) AIVDQRPSSRASSRA S365
S365-p
IVDQRPssRAssRAs
Upstream
Downstream
14 16
Effects on Modified Protein
  • activity, induced
  • protein conformation
Kinase, in vitro:
  • CAMK2A (human)
  • PKACA (human)
  • PKCA (human)
  • PKCE (human)
Putative in vivo kinases:
  • PKACA (human)
Regulatory protein:
  • FGFR1 (rat)
Treatment
  • corticosterone
  • ethanol
  • H-89
  • hypoxia
  • PD98059
  • sucrose
  • urofollitropin
GJA1 (human) IVDQRPssRAssRAs S365-p
GJA1 (mouse) IVDQRPssRAssRAs S365-p
GJA1 (rat) IVDQRPssRAssRAs S365-p
GJA1 (rabbit) IVDQRPSSRASsRAS S365
GJA1 (pig) IVDQRPSSRAsSRAS S365
GJA1 (hamster) IVDQRPSSRASSRAS S365
GJA1 (cow) IVDQRPSSRASSRAS S366
S368-p
QRPssRAssRAssRP
Upstream
Downstream
59 8
GJA1 (human)
S368-p
GJA1 (mouse)
S368-p
GJA1 (rat)
S368-p
Effects on Modified Protein
  • activity, induced
  • activity, inhibited
  • intracellular localization
Effects on Biological Processes:
  • cell growth, induced
  • cell motility, induced
Kinase, in vitro:
  • PKACA (human)
  • PKCA (cow)
  • PKCA (human)
  • PKCB (cow)
  • PKCE (human)
  • PKCG (human)
Putative in vivo kinases:
  • PKACA (human)
  • PKCA (mouse)
  • PKCA (rat)
  • PKCE (rat)
Putative upstream phosphatases:
  • PTPN2 (human)
Regulatory protein:
  • DSG4 (human)
  • GJA1 (human)
  • IP3R1 (rat)
  • PKCA (rat)
Treatment
  • 2-APB
  • acadesine
  • acute stress
  • adriamycin
  • albumin
  • angiotensin_2
  • calphostin_C
  • candesartan
  • CBX
  • CoCl2
  • corticosterone
  • DADLE
  • echinomycin
  • epsilonV1-2
  • ethanol
  • FGF2
  • GAP26
  • GF109203X
  • H-89
  • hypoxia
  • ischemia
  • isoproterenol
  • levothyroxine sodium
  • MDMA
  • melatonin
  • methimazole
  • Omega-3
  • PD98059
  • phorbol_ester
  • PKC-epsilon_translocation_inhibitor
  • rotigaptide
  • status epilepticus
  • streptozotocin
  • sucrose
  • trastuzumab
  • U0126
  • urofollitropin
GJA1 (human) QRPssRAssRAssRP S368-p
GJA1 (mouse) QRPssRAssRAssRP S368-p
GJA1 (rat) QRPssRAssRAssRP S368-p
GJA1 (rabbit) QRPSSRASsRASSRP S368
GJA1 (pig) QRPSSRAsSRASSRP S368-p
GJA1 (hamster) QRPSSRASSRASSRP S368
GJA1 (cow) QRPSSRASSRASSRP S369
S369-p
RPssRAssRAssRPR
Upstream
Downstream
14 9
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • protein conformation
Kinase, in vitro:
  • Akt1 (human)
  • CAMK2A (human)
  • PKACA (human)
  • PKCA (human)
  • PKCA (rat)
  • PKCE (human)
Putative in vivo kinases:
  • PKACA (human)
  • PKCA (rat)
Treatment
  • 2,2'-DCB
  • corticosterone
  • ethanol
  • H-89
  • ischemia
  • PD98059
  • phorbol_ester
  • sucrose
  • urofollitropin
GJA1 (human) RPssRAssRAssRPR S369-p
GJA1 (mouse) RPssRAssRAssRPR S369-p
GJA1 (rat) RPssRAssRAssRPR S369-p
GJA1 (rabbit) RPSSRASsRASSRPR S369-p
GJA1 (pig) RPSSRAsSRASSRPR S369
GJA1 (hamster) RPSSRASSRASSRPR S369
GJA1 (cow) RPSSRASSRASSRPR S370
S372-p
sRAssRAssRPRPDD
Upstream
4 6
Kinase, in vitro:
  • CAMK2A (human)
  • PKCA (human)
  • PKCE (human)
GJA1 (human) sRAssRAssRPRPDD S372-p
GJA1 (mouse) sRAssRAssRPRPDD S372-p
GJA1 (rat) sRAssRAssRPRPDD S372-p
GJA1 (rabbit) SRASsRASSRPRPDD S372
GJA1 (pig) SRAsSRASSRPRPDD S372
GJA1 (hamster) SRASSRASSRPRPDD S372
GJA1 (cow) SRASSRASSRPRPDD S373
S373-p
RAssRAssRPRPDDL
Upstream
Downstream
18 6
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Kinase, in vitro:
  • Akt1 (human)
  • CAMK2A (human)
  • PKACA (human)
  • PKCA (human)
  • PKCE (human)
Putative in vivo kinases:
  • Akt3 (rat)
  • PKACA (human)
Regulatory protein:
  • DRD2 (human)
Treatment
  • cAMP_analog
  • EGF
  • H-89
  • PD98059
  • peptide
  • urofollitropin
GJA1 (human) RAssRAssRPRPDDL S373-p
GJA1 (mouse) RAssRAssRPRPDDL S373-p
GJA1 (rat) RAssRAssRPRPDDL S373-p
GJA1 (rabbit) RASsRASSRPRPDDL S373
GJA1 (pig) RAsSRASSRPRPDDL S373
GJA1 (hamster) RASSRASSRPRPDDL S373
GJA1 (cow) RASSRASSRPRPDDL S374